@ayaemori_official: たまに付ける色素薄めカラコン好き☺️

絵森 彩
絵森 彩
Open In TikTok:
Region: JP
Friday 27 February 2026 09:01:26 GMT
16214
2438
97
59

Music

Download

Comments

user938239382029381
gem :
2026-02-28 15:33:40
0
mister_lunatic09
Mister lunatic :
You are so beautiful as always 😊
2026-02-27 23:30:54
0
stevenlezamaluque
Stvn LeLu :
2026-03-01 19:12:53
0
user8421236975874
ゆい🧸 :
明日の愛知公演楽しみ!猫耳凄すぎるスゴッ(๑°ㅁ°๑)‼✧
2026-02-27 09:08:04
2
dkj_lnwaa
だいきょじん :
猫耳あやちゃん最高や…最高や…!
2026-03-15 07:01:43
0
takun_1234567890
たーくん :
カワヨ
2026-03-01 20:12:36
0
chi_bakun0723
ちーばくん :
色素薄めカラコン👀も素敵ですねぇ☺️
2026-02-27 23:21:36
0
user4728860314693
おりまさ :
えもねこかわいい!
2026-03-06 00:22:07
0
user7822144855956
丸山泰弘 :
かわいい☺♥
2026-02-28 00:07:49
0
0udon3
おうどんさん :
表情がクッキリとするね〜 ねこ彩も可愛すぎるよ 素敵な姿をみせてくれてありがとう
2026-02-27 09:21:56
1
teine_rx0
ていね :
ビジュ最強🥰
2026-02-28 15:37:56
0
ay_ns_hn
さすけ :
にゃんにゃんねこ!!!🐈🐾 猫耳似合っててほんとに可愛いよ〜🥰
2026-02-27 12:14:46
1
ryoooya16
@りょーーや(・8・) :
髪色が素敵過ぎる
2026-03-01 01:37:32
0
user2420282186552
きゅうり :
美しすぎて目が覚めた😳開眼!
2026-02-27 21:22:35
0
lyiustaa
Yuta :
早く見れた!可愛い猫さんですね!カラコン綺麗ですね!
2026-02-27 09:03:03
0
kaitory715
kaitory :
猫耳えもりん可愛すぎ ビジュ良すぎ✨️✨ 愛知公演楽しみにしてます٩(๑>∀<๑)۶
2026-02-27 23:55:35
0
takemasa2495951947237
🍏🌶️武政🌶️🍏 :
もうめちゃくちゃ可愛すぎる
2026-03-01 10:04:21
0
unyapricot
apricot :
えもにゃん!🐈‍⬛
2026-02-27 20:45:21
0
sinpachi.484
炭酸抜きコーラ :
ふぁ!?かわよ
2026-02-27 15:20:18
0
argento_liella
アルジェント :
ああああ🥰えもねこかわいすぎるうう😭
2026-02-27 14:45:43
0
akagkagicioud3
ハムスター博士🐹🤍🩵🎨🖌🌈 :
2026-03-20 10:41:58
0
_katsuki.o_
かつき∞ :
可愛すぎ尊いですにゃん
2026-02-27 16:01:19
0
accaphcoo
赤福 :
この猫耳天才
2026-02-27 15:00:47
0
cesarlara7u7
César Lara • Enemigos :
Emorin te mando un saludo eres mi fan
2026-02-27 15:04:40
0
yuzuyuzu807
ゆず🩵🫧 :
手が滑って、本人からいいねつかないかなー
2026-02-27 09:03:11
0
To see more videos from user @ayaemori_official, please go to the Tikwm homepage.

Other Videos

Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only.  ------  What is HEMLIBRA?  HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors.  ------  What is the most important information I should know about HEMLIBRA?  HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots.  --  These serious side effects include:  • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs  • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head  --  Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total.  --  Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds).  --  The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.

About